Zacks Research Brokers Raise Earnings Estimates for Integer

Integer Holdings Co. (NYSE:ITGR) – Zacks Research raised their Q4 2024 earnings per share (EPS) estimates for Integer in a report issued on Tuesday, January 7th. Zacks Research analyst D. Dey now expects that the medical equipment provider will post earnings of $1.46 per share for the quarter, up from their previous estimate of $1.45. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q3 2026 earnings at $1.65 EPS.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter in the prior year, the firm posted $1.27 earnings per share. Integer’s revenue for the quarter was up 8.7% compared to the same quarter last year.

Several other analysts have also recently issued reports on the company. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. KeyCorp increased their price target on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Piper Sandler reiterated an “overweight” rating and set a $140.00 price target (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Finally, Citigroup increased their price target on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $145.44.

Integer Trading Up 0.5 %

Shares of NYSE ITGR opened at $133.83 on Friday. The stock’s 50 day moving average price is $135.88 and its two-hundred day moving average price is $127.85. Integer has a 52-week low of $94.56 and a 52-week high of $142.76. The stock has a market capitalization of $4.49 billion, a P/E ratio of 41.31, a PEG ratio of 1.99 and a beta of 1.12. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.

Hedge Funds Weigh In On Integer

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its holdings in Integer by 36.0% in the 4th quarter. GAMMA Investing LLC now owns 888 shares of the medical equipment provider’s stock worth $118,000 after buying an additional 235 shares in the last quarter. Versant Capital Management Inc boosted its stake in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 183 shares in the last quarter. Lord Abbett & CO. LLC boosted its stake in Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after purchasing an additional 9,754 shares in the last quarter. TD Private Client Wealth LLC boosted its stake in Integer by 15.5% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,420 shares of the medical equipment provider’s stock valued at $185,000 after purchasing an additional 191 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in Integer by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock valued at $99,408,000 after purchasing an additional 9,421 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.